Nurx is a digital healthcare company that provides accessible healthcare services directly to consumers, especially women, in sensitive health areas like sexual health, reproductive health, and general wellness. The company offers a wide array of services including birth control, PrEP for HIV prevention, STI testing, and treatment for conditions such as migraines and skin care issues. Its platform allows users to receive prescriptions and healthcare products delivered to their homes, aiming to simplify patient access to medical services.
In February 2022, the company merged with Thirty Madison, a healthcare company focused on supporting chronic conditions. The terms of the deal remain undisclosed. Post-merger, Nurx operates under the umbrella of Thirty Madison but maintains a distinct identity focused on its specific healthcare services.
Key customers and partnerships
Nurx primarily serves individuals seeking convenient and confidential access to healthcare services related to sexual health, reproductive health, and general wellness. The company particularly focuses on women's health. As of May 2024, the company had offered over 100 medications and had served over 100 million patients.
To help offer its services, the company partnered with several other startups, including TaskRabbit, CareDash, and Stride.
Funding and Financials
In August 2020, Nurx raised USD 22.5 million in an extended Series C funding round with the participation of investors including Comcast Ventures, Trustbridge, and Wittington Ventures, the investment branch of Canadian pharmacy Shoppers Drug Mart. The funds were intended to drive the company's performance toward profitability and expand its range of services.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.